[过敏特异性免疫疗法:与过敏结膜炎相关的简要概述]
Diana Lill1, Mattis Bertlich2, Eva Oppel2
1Klinik und Poliklinik für Dermatologie und Allergologie, LMU Klinikum, LMU München, Frauenlobstr. 9-11, 80337, München, Deutschland. diana.lill@med.uni-muenchen.de.
Die Ophthalmologie
|February 7, 2024
概括
过敏原特异性免疫疗法 (AIT) 通过改变免疫反应,为IgE介导的过敏提供因果治疗. 本文重点介绍了过敏性结膜炎的AIT适应症,需要临床症状和敏感化.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
背景情况:
- 过敏原特异性免疫疗法 (AIT) 是免疫球蛋白E (IgE) 介导的I型过敏的唯一因果和疾病修饰性治疗方法.
- 通过将T-助手 (Th) 2淋巴细胞对Th1的反应转移并增加过敏原特定的阻断性免疫球蛋白,AIT诱导免疫调节.
- 治疗过敏剂条例 (TAV) 规定了AIT对各种过敏状况的物质批准.
研究的目的:
- 详细说明过敏原特异性免疫疗法 (AIT) 的适用于过敏性结膜炎的说明.
- 概述启动AIT的先决条件,包括临床症状和1型敏感性.
- 要强调的是,AIT的评估和管理需要有过敏学培训的医生.
主要方法:
- 对过敏原特异性免疫疗法 (AIT) 的现有文献和临床指南的审查.
- 专注于过敏结膜炎的诊断标准和治疗方案.
- 讨论AIT疗效背后的免疫调节机制.
主要成果:
- AIT适用于过敏性鼻炎,过敏性结膜炎,过敏性喘和昆虫毒过敏.
- 过敏症状的临床表现和确认的1型敏感性对于AIT的指示至关重要.
- 皮下和/或舌下注射途径可用于AIT.
结论:
- 当满足特定的临床和免疫学标准时,可以有效地使用AIT治疗过敏结膜炎.
- 医生在过敏学方面的专业知识对于适当评估和管理AIT至关重要.
- AIT代表了管理I型过敏的重大治疗进步,提供了超出症状控制的疾病修饰.
相关概念视频
Allergic Reactions
27.4K
Overview
27.4K
Allergic Drug Reactions
843
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
843
Hypersensitivities
649
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
649
Antibody Structure
60.1K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.1K
Cross-reactivity
31.1K
Overview
31.1K
Antigens Involved in Adaptive Immunity
496
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
496


